Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Cutaneous Pathology|December 6, 2007
Lupus-like reaction to interferon at the injection site: report of five casesItziar Arrue, Ana Saiz, Pablo Luis Ortiz-Romero, et al.
Cancers|April 30, 2021
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted TherapyNuria García-Díaz, Miguel Ángel Piris, Pablo Luis Ortiz-Romero, et al.
Dermatology Online Journal|September 13, 2016
Micosis fungoide e inhibidores del TNFα: ¿riesgo o beneficio?Lidia Maroñas-Jiménez, Sara Burillo-Martínez, Fátima Tous-Romero, et al.
Dermatology (Basel, Switzerland)|June 6, 2021
Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis FungoidesChristiane Querfeld, Julia J Scarisbrick, Chalid Assaf, et al.
Dermatologic Therapy|January 20, 2019
Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case reportCristina Vico-Alonso, Alba Calleja-Algarra, Raquel Aragón-Miguel, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 28, 2020
Cost of early-stage mycosis fungoides treatments in SpainPablo Luis Ortiz-Romero, Octavio Servitje, María Teresa Estrach, et al.
The Journal of Investigative Dermatology|October 23, 2021
PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and ProgressionNuria García-Díaz, Berta Casar, Ruth Alonso-Alonso, et al.
The Journal of Allergy and Clinical Immunology|April 12, 2026
Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour GroupJoana Calvão, Adèle de Masson, Antonio Cozzio, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2021
Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanomaAlexander Mm Eggermont, Andrey Meshcheryakov, Victoria Atkinson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma RegistryCristina Muniesa, Fernando Gallardo, Ignacio García-Doval, et al.
Pageof 1